Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$53.22 USD
+0.30 (0.57%)
Updated May 10, 2024 04:00 PM ET
After-Market: $53.09 -0.13 (-0.24%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/4/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 28.89% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.67 |
Next Year | -3.06 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.66 | -2.67 | -3.06 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.70 | -0.71 | -2.89 | -3.06 |
High Estimate | -0.40 | -0.57 | -2.20 | -2.27 |
Low Estimate | -0.75 | -0.71 | -3.25 | -3.80 |
Year ago EPS | NA | -3.78 | -3.36 | -2.67 |
Year over Year Growth Est. | NA | 82.54% | 20.54% | -14.70% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.66 | -2.67 | -3.06 |
7 Days Ago | -0.60 | -0.66 | -2.67 | -3.06 |
30 Days Ago | -0.60 | -0.66 | -2.67 | -3.06 |
60 Days Ago | -0.54 | -0.66 | -2.49 | -2.81 |
90 Days Ago | -0.47 | -0.51 | -2.09 | -2.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.66 | -2.67 | -3.06 |
Zacks Consensus Estimate | -0.60 | -0.66 | -2.67 | -3.06 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.51 | -3.78 | NA | NA |
Estimate | -0.45 | -0.38 | -0.47 | NA | NA |
Difference | 0.13 | -0.13 | -3.31 | NA | -1.10 |
Surprise | 28.89% | -34.21% | -704.26% | NA | -236.53% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more